Medtronic’s latest recall of the Pipeline Vantage 027 and 021 products is likely to result in revenue losses in the ...

Shares of Medtronic (NYSE:MDT) reached a session low on Tuesday after the U.S. Food and Drug Administration (FDA) announced a ...

Medtronic's diversified product portfolio aimed at a wide range of chronic diseases spans therapeutic areas including cardiac, diabetes, chronic pain, as well as various products for acute care.

Medtronic (NYSE:MDT) recently saw a substantial price movement, climbing 10% over the last quarter. This period was marked by ...

The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", following reports of the deaths of four patients.

The clinic data shows that Evolut TAVR continues to exhibit less bioprosthetic valve dysfunction compared to Edwards Lifesciences’ (EW) SAPIEN TAVR product. I think Medtronic has already made ...

Medtronic (NYSE: MDT) recently announced a partnership with Methinks AI to enhance stroke treatment in a number of geographies.